120 related articles for article (PubMed ID: 1618746)
21. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells.
Reilly CF; McFall RC
J Biol Chem; 1991 May; 266(15):9419-27. PubMed ID: 2033043
[TBL] [Abstract][Full Text] [Related]
22. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.
Keski-Oja J; Raghow R; Sawdey M; Loskutoff DJ; Postlethwaite AE; Kang AH; Moses HL
J Biol Chem; 1988 Mar; 263(7):3111-5. PubMed ID: 3125175
[TBL] [Abstract][Full Text] [Related]
23. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells.
van den Berg EA; Sprengers ED; Jaye M; Burgess W; Maciag T; van Hinsbergh VW
Thromb Haemost; 1988 Aug; 60(1):63-7. PubMed ID: 2460966
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
Fukumoto S; Allan EH; Zeheb R; Gelehrter TD; Martin TJ
Endocrinology; 1992 Feb; 130(2):797-804. PubMed ID: 1733726
[TBL] [Abstract][Full Text] [Related]
25. Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells.
Georg B; Riccio A; Andreasen P
Mol Cell Endocrinol; 1990 Aug; 72(2):103-10. PubMed ID: 1704320
[TBL] [Abstract][Full Text] [Related]
26. Cartilage synthesizes the serine protease inhibitor PAI-1: support for the involvement of serine proteases in cartilage remodeling.
Treadwell BV; Pavia M; Towle CA; Cooley VJ; Mankin HJ
J Orthop Res; 1991 May; 9(3):309-16. PubMed ID: 1901356
[TBL] [Abstract][Full Text] [Related]
27. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
Bergonzelli GE; Kruithof EK
J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of the expression of fast-type sarcoplasmic-reticulum Ca(2+)-ATPase by thyroid hormone and insulin-like growth factor-I in the L6 muscle cell line.
Thelen MH; Muller A; Zuidwijk MJ; van der Linden GC; Simonides WS; van Hardeveld C
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):467-74. PubMed ID: 7980406
[TBL] [Abstract][Full Text] [Related]
29. Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells.
Saji M; Akamizu T; Sanchez M; Obici S; Avvedimento E; Gottesman ME; Kohn LD
Endocrinology; 1992 Jan; 130(1):520-33. PubMed ID: 1309347
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis.
Etingin OR; Hajjar DP; Hajjar KA; Harpel PC; Nachman RL
J Biol Chem; 1991 Feb; 266(4):2459-65. PubMed ID: 1824942
[TBL] [Abstract][Full Text] [Related]
33. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2.
Kumar S; Baglioni C
J Biol Chem; 1991 Nov; 266(31):20960-4. PubMed ID: 1939146
[TBL] [Abstract][Full Text] [Related]
34. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I.
Bale LK; Conover CA
Endocrinology; 1992 Aug; 131(2):608-14. PubMed ID: 1379162
[TBL] [Abstract][Full Text] [Related]
35. Thrombin induction of plasminogen activator inhibitor mRNA in human umbilical vein endothelial cells in culture.
Heaton JH; Dame MK; Gelehrter TD
J Lab Clin Med; 1992 Aug; 120(2):222-8. PubMed ID: 1500822
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes.
Heaton JH; Nebes VL; O'Dell LG; Morris SM; Gelehrter TD
Mol Endocrinol; 1989 Jan; 3(1):185-92. PubMed ID: 2536889
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes.
Kooistra T; Bosma PJ; Töns HA; van den Berg AP; Meyer P; Princen HM
Thromb Haemost; 1989 Sep; 62(2):723-8. PubMed ID: 2683191
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
40. Constitutive plasminogen activator inhibitor 1 (PAI-1) biosynthesis in human Hep G2 hepatoma cells is maintained by an autocrine factor.
Bergonzelli GE; Kruithof EK
Thromb Haemost; 1991 Aug; 66(2):222-5. PubMed ID: 1663279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
